SPO Global. Inc., Provides Shareholder Update on Visit from Quebec Government Representatives

CEO Lu Fengyu of SPO Global Inc. (OTC: SPOM) advised that the Commercial Director of the Quebec Government Office in Beijing and Qingdao; the First Secretary of the Canadian Embassy, Francis Gagnon; and the Commercial Commissioner of the Quebec Government Office in Qingdao, Ma Lin, visited SPO Global Inc’s subsidiary Gerpang Healthcare Group on November 25, 2020. Medical Chairman Lu Fengyou and senior executives attended the meeting. The Quebec Government of Canada hopes to explore the Chinese market and promote communication and cooperation between Quebec and Shandong-based-enterprises. Based on the relevant business and company development strategy of Shandong Gengbang Biotechnology Co., Ltd., the two parties discussed the possibility of cooperation with Quebec companies in related fields.

Chairman Lu Fengyou introduced the Gerpang Healthcare Group's current collaborative project, featuring products developed from the University of Toronto, and Yale University,, on the innovations related to reproductive systems, gene coating technology, and new cardiovascular and cerebrovascular technologies.

Commercial Director Francis Gagnon introduced the Quebec Enterprise Project in Canada, hoping to further international cooperation with Gengbang Medical. Then he visited the Cerebral Surgery Hospital (Jinan) to learn about the cooperation between the Cerebral Surgery Hospital and the Toronto Bridgepoint Rehabilitation Center. Commercial Director Francis Gagnon said that the Quebec government will strongly support cooperation with Gerpang Healthcare Group that is seeking to build an international chain of hospitals specializing in treatment of stokes.

About SPO Global

SPO Global Inc. (OTC Markets: SPOM) recently completed its merger with Gerpang Healthcare Group. (www.gerpanghealthcare.com). Its subsidiary, Shandong Gerpang Biotechnology Co., Ltd. is an innovative and technological private enterprise located in the pharmaceutical Valley Industrial Park of Jinan high tech Zone. Its main business scope includes biomedical R&D, medical information software development and sales, medical high-tech introduction, medical high-quality consumables production and sales, health care products, drugs, medical equipment consumables agency and sales.

Company Disclaimers: As a "penny stock" Company, within the meaning of federal and state securities law, SPO Global, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.

Forward-Looking Statements:

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.

Company Contact:

fengyoulu@gmail.com

Source: SPO Global Inc.